Aiming to find a cure for Inflammatory Bowel Diseases.

 

Kodosil Bio has identified an antibody directed at the IL-22 pathway that plays a key role in gastrointestinal autoimmune and inflammatory processes.

 
 

About

Find out more about our novel therapeutics for IBD

Learn More →

Partners

Find out more about our strategic partnerships

Learn More →